Back to Search
KATHLEEN KENDRA, PH.D.
PH.D.
Clinical Psychologist
NPI: 1265662209Individual
Specialties, Licenses & Credentials
Clinical PsychologistPrimary
Psychologist — Clinical
Code: 103TC0700X
PY0598(NV)PSY1166(HI)
Research & Publications (15)
Stereotactic radiosurgery with or without whole brain radiotherapy for patients with a single radioresistant brain metastasis.
PMID 19652578·Am J Clin Oncol·2010
8-other
Gene expression profiling reveals similarities between the in vitro and in vivo responses of immune effector cells to IFN-alpha.
PMID 18794103·Clin Cancer Res·2008
4-observational
Randomized phase II adjuvant trial of dose-dense docetaxel before or after doxorubicin plus cyclophosphamide in axillary node-positive breast cancer.
PMID 18316792·J Clin Oncol·2008
3-trial
IFN-alpha-2b-induced signal transduction and gene regulation in patient peripheral blood mononuclear cells is not enhanced by a dose increase from 5 to 10 megaunits/m2.
PMID 18316567·Clin Cancer Res·2008
8-other
Activation of extracellular signaling regulated kinase in natural killer cells and monocytes following IL-2 stimulation in vitro and in patients undergoing IL-2 immunotherapy: analysis via dual parameter flow-cytometric assay.
PMID 18193422·Cancer Immunol Immunother·2008
8-other
A randomized phase 2 trial of bevacizumab with or without daily low-dose interferon alfa-2b in metastatic malignant melanoma.
PMID 17534686·Ann Surg Oncol·2007
3-trial
Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy.
PMID 17020993·Clin Cancer Res·2006
8-other
Phase II study of weekly docetaxel and capecitabine in patients with metastatic breast cancer.
PMID 16800973·Clin Breast Cancer·2006
3-trial
Phase II trial of bevacizumab in combination with weekly docetaxel in metastatic breast cancer patients.
PMID 16707611·Clin Cancer Res·2006
3-trial
Phase I trial of combined treatment with ch14.18 and R24 monoclonal antibodies and interleukin-2 for patients with melanoma or sarcoma.
PMID 16187086·Cancer Immunol Immunother·2006
3-trial
Phase II trial of neoadjuvant chemotherapy with docetaxel followed by epirubicin in stage II/III breast cancer.
PMID 16184461·Breast Cancer Res Treat·2005
3-trial
Attitudes toward HIV Health Care Providers scale: development and validation.
PMID 15659882·AIDS Patient Care STDS·2004
8-other
Phase I clinical trial of the immunocytokine EMD 273063 in melanoma patients.
PMID 15483010·J Clin Oncol·2004
3-trial
Multiparametric flow cytometric analysis of inter-patient variation in STAT1 phosphorylation following interferon Alfa immunotherapy.
PMID 15339971·J Natl Cancer Inst·2004
8-other
A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanoma.
PMID 12679797·Cancer Gene Ther·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6110 PLUMAS ST
RENO, NV 89519 - Phone
- (775) 786-7200
Quick Facts
- NPI
- 1265662209
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 15
Are you this provider?
Claim Your Profile